Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,555 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intratumoral immunization: a new paradigm for cancer therapy.
Marabelle A, Kohrt H, Caux C, Levy R. Marabelle A, et al. Among authors: levy r. Clin Cancer Res. 2014 Apr 1;20(7):1747-56. doi: 10.1158/1078-0432.CCR-13-2116. Clin Cancer Res. 2014. PMID: 24691639 Free PMC article.
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.
Kohrt HE, Thielens A, Marabelle A, Sagiv-Barfi I, Sola C, Chanuc F, Fuseri N, Bonnafous C, Czerwinski D, Rajapaksa A, Waller E, Ugolini S, Vivier E, Romagné F, Levy R, Bléry M, André P. Kohrt HE, et al. Among authors: levy r. Blood. 2014 Jan 30;123(5):678-86. doi: 10.1182/blood-2013-08-519199. Epub 2013 Dec 10. Blood. 2014. PMID: 24326534 Free PMC article.
Dendritic cell vaccines for cancer immunotherapy.
Timmerman JM, Levy R. Timmerman JM, et al. Among authors: levy r. Annu Rev Med. 1999;50:507-29. doi: 10.1146/annurev.med.50.1.507. Annu Rev Med. 1999. PMID: 10073291 Review.
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
Kohrt HE, Houot R, Weiskopf K, Goldstein MJ, Scheeren F, Czerwinski D, Colevas AD, Weng WK, Clarke MF, Carlson RW, Stockdale FE, Mollick JA, Chen L, Levy R. Kohrt HE, et al. Among authors: levy r. J Clin Invest. 2012 Mar;122(3):1066-75. doi: 10.1172/JCI61226. Epub 2012 Feb 13. J Clin Invest. 2012. PMID: 22326955 Free PMC article. Retracted.
Combination strategies to enhance antitumor ADCC.
Kohrt HE, Houot R, Marabelle A, Cho HJ, Osman K, Goldstein M, Levy R, Brody J. Kohrt HE, et al. Among authors: levy r. Immunotherapy. 2012 May;4(5):511-27. doi: 10.2217/imt.12.38. Immunotherapy. 2012. PMID: 22642334 Free PMC article. Review.
Targeting CD137 enhances the efficacy of cetuximab.
Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R. Kohrt HE, et al. Among authors: levy r. J Clin Invest. 2014 Jun;124(6):2668-82. doi: 10.1172/JCI73014. Epub 2014 May 16. J Clin Invest. 2014. PMID: 24837434 Free PMC article. Retracted.
4,555 results